232 related articles for article (PubMed ID: 32065276)
21. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
[TBL] [Abstract][Full Text] [Related]
22. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
[TBL] [Abstract][Full Text] [Related]
23. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
24. Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.
Song W; Jeong JY; Jeon HG; Seo SI; Jeon SS; Choi HY; Lee HM; Sung HH
Int J Surg; 2019 Jun; 66():12-17. PubMed ID: 31018160
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
26. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
27. Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
Ikeda M; Matsumoto K; Hirayama T; Koguchi D; Murakami Y; Matsuda D; Okuno N; Utsunomiya T; Taoka Y; Irie A; Iwamura M
Clin Genitourin Cancer; 2018 Jun; 16(3):e669-e675. PubMed ID: 29239844
[TBL] [Abstract][Full Text] [Related]
28. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
[TBL] [Abstract][Full Text] [Related]
30. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
31. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
[TBL] [Abstract][Full Text] [Related]
32. Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma.
Abdul-Muhsin H; De Lucia N; Singh V; Faraj K; Rose K; Cha S; Zhang N; Judge N; Navaratnam A; Tyson M; Ho T; Jacobsohn K; Castle E
Urol Oncol; 2021 Feb; 39(2):133.e9-133.e16. PubMed ID: 33069555
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
Seisen T; Krasnow RE; Bellmunt J; Rouprêt M; Leow JJ; Lipsitz SR; Vetterlein MW; Preston MA; Hanna N; Kibel AS; Sun M; Choueiri TK; Trinh QD; Chang SL
J Clin Oncol; 2017 Mar; 35(8):852-860. PubMed ID: 28045620
[TBL] [Abstract][Full Text] [Related]
34. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
[TBL] [Abstract][Full Text] [Related]
36. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
[TBL] [Abstract][Full Text] [Related]
38. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
[TBL] [Abstract][Full Text] [Related]
39. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
[TBL] [Abstract][Full Text] [Related]
40. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
